| Benjamin A Feinzimer, DO | |
|
6308 8th Ave, Kenosha, WI 53143-5031 | |
| (414) 290-6720 | |
| (414) 290-6755 |
| Full Name | Benjamin A Feinzimer |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 16 Years |
| Location | 6308 8th Ave, Kenosha, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205003142 | NPI | - | NPPES |
| P0104356 | Other | WI | MEDICARE RAILROAD |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northshore University Healthsystem - Evanston Hospital | Evanston, IL | Hospital |
| Beaver Dam Community Hospital Dba Marshfield Medical Center - Beaver Dam | Beaver dam, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ihc-beaver Dam Emergency Physicians, Llc | 8123129657 | 19 |
News Archive
A multidisciplinary team from the Universitat Politècnica de València, Universitat de València, Universitat Jaume I, University General Hospital from Valencia and the Biomedical Research Network Centre on Physiopathology of Obesity and Nutrition (CIBERobn) is developing a study on the effectiveness of active video games in children and teenagers (know as "exergaming platforms") for exercising and improving their health and fitness.
A new rare disease has been identified. Louise Benge's started having difficulty in walking when she was 25. She developed hardening and pain over her calves and hands. She worsened over the next 20 years. Her family physician in Mount Vernon, Ky., was at a loss, as were a vascular specialist, a hand specialist and a kidney specialist. Her two sisters and two brothers had the problem too, but no doctor could understand why.
Research reported December 11 in the journal Advanced Materials describes a potentially promising strategy for encouraging the regeneration of damaged central nervous system cells known as neurons.
The outcome of chemotherapy treatment for acute lymphoblastic leukemia (ALL) depends not only on the acquired genetic make-up of the leukemic cells, but on genes that children inherit from their parents. This study, from investigators at St. Jude Children's Research Hospital, is published in the online edition of Blood.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
› Verified 7 days ago
| Entity Name | Emergency Medicine Specialists Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568413524 PECOS PAC ID: 8729975461 Enrollment ID: O20040228000032 |
News Archive
A multidisciplinary team from the Universitat Politècnica de València, Universitat de València, Universitat Jaume I, University General Hospital from Valencia and the Biomedical Research Network Centre on Physiopathology of Obesity and Nutrition (CIBERobn) is developing a study on the effectiveness of active video games in children and teenagers (know as "exergaming platforms") for exercising and improving their health and fitness.
A new rare disease has been identified. Louise Benge's started having difficulty in walking when she was 25. She developed hardening and pain over her calves and hands. She worsened over the next 20 years. Her family physician in Mount Vernon, Ky., was at a loss, as were a vascular specialist, a hand specialist and a kidney specialist. Her two sisters and two brothers had the problem too, but no doctor could understand why.
Research reported December 11 in the journal Advanced Materials describes a potentially promising strategy for encouraging the regeneration of damaged central nervous system cells known as neurons.
The outcome of chemotherapy treatment for acute lymphoblastic leukemia (ALL) depends not only on the acquired genetic make-up of the leukemic cells, but on genes that children inherit from their parents. This study, from investigators at St. Jude Children's Research Hospital, is published in the online edition of Blood.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
› Verified 7 days ago
| Entity Name | Green Bay Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588612212 PECOS PAC ID: 6901879303 Enrollment ID: O20040813001226 |
News Archive
A multidisciplinary team from the Universitat Politècnica de València, Universitat de València, Universitat Jaume I, University General Hospital from Valencia and the Biomedical Research Network Centre on Physiopathology of Obesity and Nutrition (CIBERobn) is developing a study on the effectiveness of active video games in children and teenagers (know as "exergaming platforms") for exercising and improving their health and fitness.
A new rare disease has been identified. Louise Benge's started having difficulty in walking when she was 25. She developed hardening and pain over her calves and hands. She worsened over the next 20 years. Her family physician in Mount Vernon, Ky., was at a loss, as were a vascular specialist, a hand specialist and a kidney specialist. Her two sisters and two brothers had the problem too, but no doctor could understand why.
Research reported December 11 in the journal Advanced Materials describes a potentially promising strategy for encouraging the regeneration of damaged central nervous system cells known as neurons.
The outcome of chemotherapy treatment for acute lymphoblastic leukemia (ALL) depends not only on the acquired genetic make-up of the leukemic cells, but on genes that children inherit from their parents. This study, from investigators at St. Jude Children's Research Hospital, is published in the online edition of Blood.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
› Verified 7 days ago
| Entity Name | Ihc-beaver Dam Emergency Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912109836 PECOS PAC ID: 8123129657 Enrollment ID: O20070727000027 |
News Archive
A multidisciplinary team from the Universitat Politècnica de València, Universitat de València, Universitat Jaume I, University General Hospital from Valencia and the Biomedical Research Network Centre on Physiopathology of Obesity and Nutrition (CIBERobn) is developing a study on the effectiveness of active video games in children and teenagers (know as "exergaming platforms") for exercising and improving their health and fitness.
A new rare disease has been identified. Louise Benge's started having difficulty in walking when she was 25. She developed hardening and pain over her calves and hands. She worsened over the next 20 years. Her family physician in Mount Vernon, Ky., was at a loss, as were a vascular specialist, a hand specialist and a kidney specialist. Her two sisters and two brothers had the problem too, but no doctor could understand why.
Research reported December 11 in the journal Advanced Materials describes a potentially promising strategy for encouraging the regeneration of damaged central nervous system cells known as neurons.
The outcome of chemotherapy treatment for acute lymphoblastic leukemia (ALL) depends not only on the acquired genetic make-up of the leukemic cells, but on genes that children inherit from their parents. This study, from investigators at St. Jude Children's Research Hospital, is published in the online edition of Blood.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin A Feinzimer, DO 111 E Wisconsin Ave, Suite 2000, Milwaukee, WI 53202-4815 Ph: (414) 290-6720 | Benjamin A Feinzimer, DO 6308 8th Ave, Kenosha, WI 53143-5031 Ph: (414) 290-6720 |
News Archive
A multidisciplinary team from the Universitat Politècnica de València, Universitat de València, Universitat Jaume I, University General Hospital from Valencia and the Biomedical Research Network Centre on Physiopathology of Obesity and Nutrition (CIBERobn) is developing a study on the effectiveness of active video games in children and teenagers (know as "exergaming platforms") for exercising and improving their health and fitness.
A new rare disease has been identified. Louise Benge's started having difficulty in walking when she was 25. She developed hardening and pain over her calves and hands. She worsened over the next 20 years. Her family physician in Mount Vernon, Ky., was at a loss, as were a vascular specialist, a hand specialist and a kidney specialist. Her two sisters and two brothers had the problem too, but no doctor could understand why.
Research reported December 11 in the journal Advanced Materials describes a potentially promising strategy for encouraging the regeneration of damaged central nervous system cells known as neurons.
The outcome of chemotherapy treatment for acute lymphoblastic leukemia (ALL) depends not only on the acquired genetic make-up of the leukemic cells, but on genes that children inherit from their parents. This study, from investigators at St. Jude Children's Research Hospital, is published in the online edition of Blood.
Pro-Pharmaceuticals, Inc., a developer of therapeutics that target Galectin receptors to treat cancer and fibrosis, today reported its financial results for the second quarter and the first six months ended June 30, 2010. These results are included in the Company's Quarterly Report on Form 10-Q, which has been filed with the SEC.
› Verified 7 days ago
David Eric Farkas, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Aurora Medical Center, Kenosha, WI 53142 Phone: 262-697-7000 Fax: 630-734-1560 | |
Ms. Kimberly Roberson, PA Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Terry Zehr, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-7000 | |
Manuel A. Rivera, M.D. Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 4536 22nd Ave, Kenosha, WI 53140 Phone: 262-656-0044 Fax: 262-653-2218 | |
Mounica D Robinson, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 10400 75th St, Kenosha, WI 53142 Phone: 262-948-5600 | |
Therese Marie Whitt, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 10400 75th St, Aurora Medical Center, Kenosha, WI 53142 Phone: 262-697-7000 Fax: 630-734-1560 |